IBA Investments

IBA (Ion Beam Applications) is a global leader in medical technology, specifically in the field of proton therapy and radiopharmaceutical production. Headquartered in Belgium, the company designs and manufactures advanced particle accelerators used for high-precision cancer treatment and the diagnosis of various diseases. Their flagship proton therapy systems, such as the Proteus®ONE and Proteus®PLUS, allow for targeted radiation that minimizes damage to healthy tissue. Additionally, IBA's RadioPharma division provides cyclotrons for the production of essential isotopes used in PET and SPECT imaging. The company also offers dosimetry solutions and industrial sterilization services, maintaining a dominant position in the oncology and medical imaging markets.